Rating History for Agile Therapeutics (AGRX) by RBC Capital

More Stocks Rated by RBC Capital | Latest Ratings for AGRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/17/2025 Daniel Busb Maintain Outperform
(N/A)		 925.00
(860.00)		  
 		   Details